These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7243794)

  • 1. Drug treatment of hypertriglyceridaemia in chronic uraemic patients: preliminary report on D,L-carnitine and thiadenol.
    Giorcelli G; Vacha G; Icardi GP
    Proc Eur Dial Transplant Assoc; 1980; 17():367-71. PubMed ID: 7243794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of omega-3 fatty acid supplementation to plasma lipid peroxidation in predialysis patients with hypertriglyceridaemia.
    Richard MJ; Sirajeddine MK; Cordonnier D; Tricot F; Foulon T; Mouneimne A; Maurizi J
    Eur J Med; 1993 Jan; 2(1):15-8. PubMed ID: 8257999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of L-carnitine on lipid metabolism in patients on chronic haemodialysis.
    Yderstraede KB; Pedersen FB; Dragsholt C; Trostmann A; Laier E; Larsen HF
    Nephrol Dial Transplant; 1987; 1(4):238-41. PubMed ID: 3110681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low dose clofibrate in the treatment of hypertriglyceridemia in hemodialysis patients (author's transl)].
    Jarillo MD; Coca MC; Díaz Rubio C; Bello I; Gutiérrez-Millet V; Ruilope LM; Rodicio JL; Alvarez Ude F
    Med Clin (Barc); 1980 Nov; 75(8):334-7. PubMed ID: 7442334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-carnitine inhibits a subset of platelet activation responses in chronic uraemia.
    Bonomini M; Sirolli V; Dottori S; Amoroso L; Di Liberato L; Arduini A
    Nephrol Dial Transplant; 2007 Sep; 22(9):2623-9. PubMed ID: 17478491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
    Glöggler A; Bulla M; Fürst P
    Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thiadenol in the short-term treatment of patients with blood lipid disorders].
    Di Stefano F; Patane S; Gatto A
    Minerva Med; 1980 Mar; 71(8):567-74. PubMed ID: 7360386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia.
    Stefanutti C; Vivenzio A; Lucani G; Di Giacomo S; Lucani E
    Clin Ter; 1998; 149(2):115-9. PubMed ID: 9780475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of carnitine administration in patients with chronic renal failure undergoing periodic dialysis, evaluated by computerized electromyography.
    Rocchi L; Feola I; Calvani M; D'Iddio S; Alfarone C; Frascarelli M
    Drugs Exp Clin Res; 1986; 12(8):707-11. PubMed ID: 3757765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dyslipoproteinemia and chronic kidney failure].
    Zahálková J; Vaverková H; Kristof V
    Vnitr Lek; 2000 Sep; 46(9):539-46. PubMed ID: 11344648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
    Reuter SE; Faull RJ; Ranieri E; Evans AM
    Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-carnitine in haemodialysed patients. Changes in lipid pattern.
    Casciani CU; Caruso U; Cravotto E; D'Iddio S; Corsi M; Pola P; Savi L; Grilli M
    Arzneimittelforschung; 1982; 32(3):293-7. PubMed ID: 7200788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of L-carnitine administration on erythropoietin use in thalassemic minor haemodialysis patients.
    Di Iorio BR; Guastaferro P; Cillo N; Cucciniello E; Bellizzi V
    Nephrol Dial Transplant; 2007 Mar; 22(3):954-5; author reply 955-6. PubMed ID: 17132710
    [No Abstract]   [Full Text] [Related]  

  • 16. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
    Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
    Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
    Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
    Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
    Reuter SE; Faull RJ; Evans AM
    Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of thiadenol in diabetic hyperdyslipemia as compared with clofibrate].
    Nicrosini F; Pasotti C
    Clin Ter; 1979 Aug; 90(3):241-50. PubMed ID: 553752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.